Fusarium fungaemia in immunocompromised patients
- 1 June 2004
- journal article
- case report
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 10 (6) , 499-501
- https://doi.org/10.1111/j.1469-0691.2004.00859.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Successsful Voriconazole Treatment of Disseminated Fusarium Infection in an Immunocompromised PatientClinical Infectious Diseases, 2003
- Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal InfectionsClinical Infectious Diseases, 2003
- Epidemiology, Molecular Mycology, and Environmental Sources ofFusariumInfection in Patients with CancerInfection Control & Hospital Epidemiology, 2002
- Comparison of the E-test with the NCCLS M38-P Method for Antifungal Susceptibility Testing of Common and Emerging Pathogenic Filamentous FungiJournal of Clinical Microbiology, 2001
- Prospective Study of Fungaemia in a Single Cancer Institution over a 10-y Period: Aetiology, Risk Factors, Consumption of Antifungals and Outcome in 140 PatientsScandinavian Journal of Infectious Diseases, 2001
- Breakthrough Fungemia Appearing during Empiric Therapy with Amphotericin BChemotherapy, 1997
- Opportunistic fusarial infections in humansEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- Fusarium Infection with Unusual Skin Lesions in a Patient with Acute Lymphocytic LeukemiaDermatology, 1995
- Catheter-Related Fusarium solani Fungemia and Pulmonary Infection in a Patient with Leukemia in RemissionClinical Infectious Diseases, 1993
- The Emerging Role of Fusarium Infections in Patients with CancerMedicine, 1988